Canada markets open in 1 hour 15 minutes

G1 Therapeutics, Inc. (G1H.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.4320-0.2220 (-6.08%)
At close: 08:01AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 184.03M
Enterprise Value 159.52M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.31
Price/Book (mrq)5.44
Enterprise Value/Revenue 1.93
Enterprise Value/EBITDA -4.65

Trading Information

Stock Price History

Beta (5Y Monthly) 1.70
52-Week Change 323.90%
S&P500 52-Week Change 323.10%
52 Week High 34.4180
52 Week Low 31.0350
50-Day Moving Average 33.4248
200-Day Moving Average 32.3839

Share Statistics

Avg Vol (3 month) 3863
Avg Vol (10 day) 3N/A
Shares Outstanding 552.3M
Implied Shares Outstanding 653.62M
Float 843.87M
% Held by Insiders 111.65%
% Held by Institutions 130.03%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -58.13%
Operating Margin (ttm)-60.04%

Management Effectiveness

Return on Assets (ttm)-15.96%
Return on Equity (ttm)-92.13%

Income Statement

Revenue (ttm)82.51M
Revenue Per Share (ttm)1.60
Quarterly Revenue Growth (yoy)45.10%
Gross Profit (ttm)N/A
EBITDA -39.01M
Net Income Avi to Common (ttm)-47.97M
Diluted EPS (ttm)-0.8700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)82.16M
Total Cash Per Share (mrq)1.57
Total Debt (mrq)57.17M
Total Debt/Equity (mrq)161.57%
Current Ratio (mrq)3.87
Book Value Per Share (mrq)0.68

Cash Flow Statement

Operating Cash Flow (ttm)-38.34M
Levered Free Cash Flow (ttm)-19.99M